Alisol Triterpenoids Exhibit Triple Modulatory Mechanisms on the Cell Membrane to Overcome Cancer Multidrug Resistance
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s521116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Jing-Yi Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan, Republic of China. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Drug Resistance, Neoplasm, Cell Membrane, Antineoplastic Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan, Republic of China.
- Department of Pharmacy, College of Pharmacy, China Medical University, Taichung City, Taiwan, Republic of China.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, Republic of China.
- Department of Pharmacy, E-Da Cancer Hospital, Kaohsiung, Taiwan, Republic of China.
ORCID-Profile: Ying-Tzu Chang
Zitieren
APA
Chen, J. Y., Chang, Y. T., Ho, Y. C., & Teng, Y. N. (2025). Alisol Triterpenoids Exhibit Triple Modulatory Mechanisms on the Cell Membrane to Overcome Cancer Multidrug Resistance. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s521116
Vancouver
Chen JY, Chang YT, Ho YC, Teng YN. Alisol Triterpenoids Exhibit Triple Modulatory Mechanisms on the Cell Membrane to Overcome Cancer Multidrug Resistance. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s521116
BibTeX
@article{Chen2025,
author = {Chen, Jing-Yi and Chang, Ying-Tzu and Ho, Yu-Cheng and Teng, Yu-Ning},
title = {Alisol Triterpenoids Exhibit Triple Modulatory Mechanisms on the Cell Membrane to Overcome Cancer Multidrug Resistance},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s521116}
}
EUVIMED